Additionally, GBM cells expressing bradykinin receptor 2 (BKR2) bind to bradykinin, which is physiologically present in the brain’s blood vessels and is an endothelial cell product that is increased during tumor progression [108,109]. The gene discussed is BDKRB2; the disease is glioblastoma.